Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$49.57 USD
-1.25 (-2.46%)
Updated Jul 24, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.23 | 3.96% |
Earnings Summary
For their last quarter, Keros Therapeutics (KROS) reported earnings of -$1.21 per share, beating the Zacks Consensus Estimate of $-1.31 per share. This reflects a positive earnings surprise of 7.63%. Look out for KROS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.23 per share, reflecting a year-over-year increase of 3.15%.
Earnings History
Price & Consensus
Zacks News for KROS
Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?
KROS: What are Zacks experts saying now?
Zacks Private Portfolio Services